2. Metabolic Enzyme/Protease
  3. Drug Metabolite Cytochrome P450
  4. 7-Epi-docetaxel

7-Epi-docetaxel  (Synonyms: 4-epi-Docetaxel; 7-Epidocetaxel; 7-Epitaxotere)

Cat. No.: HY-16676 Purity: 98.76%
COA
SDS
Handling Instructions Technical Support

7-Epi-docetaxel (4-epi-Docetaxel; 7-Epidocetaxel; 7-Epitaxotere) is the major C7 epimeric impurity/in vivo metabolite of Docetaxel (HY-B0011). 7-Epi-docetaxel acts as a potent allosteric activator of rhCYP1B1. 7-Epi-docetaxel exhibits certain cell line-specific anti-migratory activity. 7-Epi-docetaxel can be used in research related to melanoma and lung adenocarcinoma.

For research use only. We do not sell to patients.

7-Epi-docetaxel

7-Epi-docetaxel Chemical Structure

CAS No. : 153381-68-1

Size Price Stock Quantity
1 mg In-stock
5 mg In-stock
10 mg In-stock
50 mg   Get quote  
100 mg   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Customer Review

Based on 1 publication(s) in Google Scholar

7-Epi-docetaxel Related Antibodies

Top Publications Citing Use of Products

View All Cytochrome P450 Isoform Specific Products:

View All Isoforms
CYP1 CYP2 CYP3 CYP4 CYP11 CYP17 Aromatase/CYP19A1 CYP26 CYP51 CYP1A2 CYP2D6 CYP2C9 CYP2C19 CYP3A CYP3A4 CYP17A1

  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

7-Epi-docetaxel (4-epi-Docetaxel; 7-Epidocetaxel; 7-Epitaxotere) is the major C7 epimeric impurity/in vivo metabolite of Docetaxel (HY-B0011). 7-Epi-docetaxel acts as a potent allosteric activator of rhCYP1B1. 7-Epi-docetaxel exhibits certain cell line-specific anti-migratory activity. 7-Epi-docetaxel can be used in research related to melanoma and lung adenocarcinoma[2].

IC50 & Target[1]

CYP1B1

 

In Vitro

7-Epi-docetaxel (3-100 μM) potently activates recombinant human CYP1B1-mediated EROD activity: the activity increases by more than 7-fold at 10 μM, 4.8-fold at 30 μM, and 4.7-fold at 100 μM, while no significant effect is observed at 3 μM[1].
7-Epi-docetaxel (1 μM) is not metabolized in vitro by recombinant human CYP1B1 expressed in insect cell Supersomes[1].
7-Epi-docetaxel (0.01-10 μM; 24-72 h) inhibits the proliferation of human lung adenocarcinoma A549 cells and mouse melanoma B16F10 cells in a concentration- and time-dependent manner, with its IC50 values ranging from 0.024 nM to 2500 nM depending on the cell line and incubation time[2].
7-Epi-docetaxel (2 nM; 24 h) exhibits 58% antimetastatic activity against human lung adenocarcinoma cell line A549 and 21% antimetastatic activity against mouse melanoma cell line B16F10[2].
7-Epi-docetaxel (2 nM; 24 h) exerts no significant effect on the activities of MMP-2 or MMP-9 in human lung adenocarcinoma cells A549 or mouse melanoma cells B16F10[2].
7-Epi-docetaxel (2-25 nM; 24-48 h) arrests human lung adenocarcinoma A549 cells at the S, G2-M and G0-G1 phases in a concentration- and time-dependent manner[2].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

7-Epi-docetaxel Related Antibodies

Cell Cytotoxicity Assay[2]

Cell Line: A549 human lung adenocarcinoma cells, B16F10 mouse melanoma cells
Concentration: 0.01 nM, 1 μM, 10 μM
Incubation Time: 24 h, 48 h, 72 h
Result: Exhibited an IC50 of 6.5 nM after 24 h, 0.024 nM after 48 h, and 0.112 nM after 72 h against A549 cells.
Exhibited an IC50 of 2500 nM after 24 h, 0.512 nM after 48 h, and 0.3 nM after 72 h against B16F10 cells.
Showed concentration- and time-dependent inhibition of cell proliferation.

Cell Migration Assay [2]

Cell Line: A549 human lung adenocarcinoma cells, B16F10 mouse melanoma cells
Concentration: 2 nM
Incubation Time: 24 h
Result: Resulted in 41.92% wound coverage, corresponding to 58% anti-metastatic activity against A549 cells.
Resulted in 79.01% wound coverage, corresponding to 21% anti-metastatic activity against B16F10 cells.

Cell Cycle Analysis[2]

Cell Line: A549 human lung adenocarcinoma cells
Concentration: 2 nM, 10 nM, 25 nM
Incubation Time: 24 h, 48 h
Result: Caused no changes in S or G2-M phase after 24 h or 48 h treatment at 2 nM.
Caused 1.8-fold increased accumulation of cells in S phase and 2.1-fold increased accumulation in G2-M phase compared to untreated cells, plus 16% increased arrest in G0-G1 phase compared to TXT after 24 h treatment at 10 nM.
Caused increased arrest in S phase compared to 24 h treatment, no significant change in G2-M phase, and 2.41-fold increased accumulation in G0-G1 phase compared to TXT after 48 h treatment at 10 nM.
Resulted in cell cycle distribution almost similar to that at 10 nM concentration at 25 nM.
In Vivo

7-Epi-docetaxel (4 mg/kg; i.v.; single dose) co-administered with Docetaxel increases Docetaxel-induced body weight loss and does not suppress pulmonary melanoma metastasis in female C57BL/6 mice[2].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: C57BL/6 (female, 6-8 weeks old, 18-22 g, intravenous injection of 0.1 million B16F10 melanoma cells)[2]
Dosage: 4 mg/kg
Administration: i.v.; single dose
Result: Showed 1.56-, 1.5-, 1.35-, and 1.12-fold increased mean group weight loss at days 2, 4, 6, and 8 post-dose respectively compared to docetaxel alone.
Did not reduce pulmonary metastatic colony formation relative to untreated control and docetaxel-only groups.
Molecular Weight

807.88

Formula

C43H53NO14
CAS No.
Appearance

Solid

Color

White to light yellow

SMILES

CC(O[C@@]1([C@](C[C@H]2O)([H])OC1)[C@@]([C@@]2(C3=O)C)([H])[C@@H]([C@@](C4(C)C)(C[C@H](OC([C@H](O)[C@H](C5=CC=CC=C5)NC(OC(C)(C)C)=O)=O)C(C)=C4[C@H]3O)O)OC(C6=CC=CC=C6)=O)=O
Shipping

Room temperature in continental US; may vary elsewhere.
Storage
Powder -20°C 3 years
4°C 2 years
In solvent -80°C 2 years
-20°C 1 year
Solvent & Solubility
In Vitro: 

DMSO : 100 mg/mL (123.78 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

Preparing
Stock Solutions
Concentration Solvent Mass 1 mg 5 mg 10 mg
1 mM 1.2378 mL 6.1890 mL 12.3781 mL
5 mM 0.2476 mL 1.2378 mL 2.4756 mL
View the Complete Stock Solution Preparation Table

* Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.

  • Molarity Calculator

  • Dilution Calculator

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass
=
Concentration
×
Volume
×
Molecular Weight *

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start)

C1

×
Volume (start)

V1

=
Concentration (final)

C2

×
Volume (final)

V2

In Vivo Dissolution Calculator
Please enter the basic information of animal experiments:

Dosage

mg/kg

Animal weight
(per animal)

g

Dosing volume
(per animal)

μL

Number of animals

Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Calculation results:
Working solution concentration: mg/mL
Purity & Documentation
References

Complete Stock Solution Preparation Table

* Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.

Optional Solvent Concentration Solvent Mass 1 mg 5 mg 10 mg 25 mg
DMSO 1 mM 1.2378 mL 6.1890 mL 12.3781 mL 30.9452 mL
5 mM 0.2476 mL 1.2378 mL 2.4756 mL 6.1890 mL
10 mM 0.1238 mL 0.6189 mL 1.2378 mL 3.0945 mL
15 mM 0.0825 mL 0.4126 mL 0.8252 mL 2.0630 mL
20 mM 0.0619 mL 0.3095 mL 0.6189 mL 1.5473 mL
25 mM 0.0495 mL 0.2476 mL 0.4951 mL 1.2378 mL
30 mM 0.0413 mL 0.2063 mL 0.4126 mL 1.0315 mL
40 mM 0.0309 mL 0.1547 mL 0.3095 mL 0.7736 mL
50 mM 0.0248 mL 0.1238 mL 0.2476 mL 0.6189 mL
60 mM 0.0206 mL 0.1032 mL 0.2063 mL 0.5158 mL
80 mM 0.0155 mL 0.0774 mL 0.1547 mL 0.3868 mL
100 mM 0.0124 mL 0.0619 mL 0.1238 mL 0.3095 mL
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.

7-Epi-docetaxel Related Classifications

Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Keywords:

7-Epi-docetaxel153381-68-14-epi-Docetaxel 7-Epidocetaxel 7-EpitaxotereDrug MetaboliteCytochrome P450CYPsA549 human lung adenocarcinoma cellsMMP-2B16F10 mouse melanoma cellsrecombinant human CYP1B1insect cell Supersomesmelanomalung adenocarcinomaMMP-9rhCYP1B1C57BL/6 miceInhibitorinhibitorinhibit

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

  

Requested Quantity *

Applicant Name *

 

Salutation

Email Address *

 

Phone Number *

Department

 

Organization Name *

City

State

Country or Region *

      

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
7-Epi-docetaxel
Cat. No.:
HY-16676
Quantity:
MCE Japan Authorized Agent:

Customer Review

Thank You for Your Feedback!

Request for HNMR Report

Please fill out this form to request the QC report. We will send it to your Email address shortly.

Your information is safe with us. * Required Fields.

Product Name

  

Lot #

Applicant Name *

 

Email Address *

Phone Number

 

Department *

Organization Name *

 

Country or Region *

Remarks

SAFETY DATA SHEET (SDS)

English - EN (393 KB) Français - FR (393 KB) Deutsch - DE (393 KB) Norwegian - NO (393 KB) Español - ES (393 KB) Swedish - SV (393 KB) Italian - IT (393 KB) Korean - KR (393 KB) Portuguese - PT (393 KB)

Request for HNMR Report

We have received your request and will respond to you as soon as possible.